Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada

NEXT STORY
SELLAS Advances Galinpepimut-S (GPS) in Combination with KEYTRUDA® (pembrolizumab) Program with Dosing of First Patient in Phase 1/2 Basket Study
PREV STORY
Forty Seven Inc. to Present at Canaccord Genuity 39th Annual Growth Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Argos Therapeutics to Host Investor Day on Wednesday, December 7, 2016

Event to be held at NASDAQ MarketSite in New York City from 8:00-11:00 a.m. ...

author_avatar
NASDAQ Market News

APHL Receives $16.5 Million Award for Newborn Screening Program Quality Improvements

Silver Spring, MD, Aug. 07, 2018 (GLOBE NEWSWIRE) -- The Association of Public Health ...

author_avatar
NASDAQ Market News

Oncobiologics Closes on Final Portion of $15 Million Senior Secured Note and Warrant Offering

CRANBURY, N.J., June 01, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News